Expert Review of Neurotherapeutics
Volume 24, 2024 - Issue 3
Drug Profile
Evaluating fenfluramine hydrochloride as an oral solution for the treatment of seizures associated with Lennox-Gastaut syndrome
Frank M. C. Besaga Child and Adolescent Mental Health Services (CAMHS), East London NHS Foundation Trust, Bedford, UK;b School of Pharmacy, University College London, London, UK;c Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UKCorrespondence[email protected]
https://orcid.org/0000-0002-4530-7933View further author information
https://orcid.org/0000-0002-4530-7933View further author information, Michael J. Vaseya Child and Adolescent Mental Health Services (CAMHS), East London NHS Foundation Trust, Bedford, UKhttps://orcid.org/0000-0003-1983-3531View further author information
https://orcid.org/0000-0003-1983-3531View further author information & Richard F. M. Chind Muir Maxwell Epilepsy Centre, The University of Edinburgh, Edinburgh, UK;e Department of Paediatric Neurosciences, Royal Hospital for Children and Young People, Edinburgh, UKhttps://orcid.org/0000-0002-7256-3027View further author information
https://orcid.org/0000-0002-7256-3027View further author information